Showing results (11-20 of 86) with videos related to
Sort By:
Pageof 9
The Journal of Steroid Biochemistry and Molecular Biology|May 29, 2020
Efficacy of a novel orally active SERD AZD9496 against hormone dependent post-menopausal breast cancer depends on inhibition of cellular aromatase activityArmina Kazi, Olga Goloubeva, Amanda Schech, et al.Cancer|April 7, 2009
Proliferative rate in endoscopic ultrasound fine-needle aspiration of pancreatic endocrine tumors: correlation with clinical behaviorBorislav A Alexiev, Peter E Darwin, Olga Goloubeva, et al.Journal of Comparative Effectiveness Research|May 11, 2022
Cost-effectiveness of concurrent radiation with cetuximab or chemotherapy in older patients with oropharyngeal cancerHusam Albarmawi, Kevin J Cullen, Ranee Mehra, et al.Head & Neck|October 11, 2021
Treatment modalities, adverse events, and survival outcomes in older patients with head and neck squamous cell carcinomaSania Amr, Dina Ioffe, Ikumi Suzuki, et al.The Journal of Steroid Biochemistry and Molecular Biology|June 22, 2005
Model systems: mechanisms involved in the loss of sensitivity to letrozoleAngela Brodie, Danijela Jelovac, Gauri Sabnis, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2005
Therapeutic observations in MCF-7 aromatase xenograftsAngela Brodie, Danijela Jelovac, Luciana Macedo, et al.Breast Cancer Research and Treatment|July 16, 2011
Frondoside A inhibits breast cancer metastasis and antagonizes prostaglandin E receptors EP4 and EP2Xinrong Ma, Namita Kundu, Peter D Collin, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|June 16, 2009
Efficacy of aprepitant in patients receiving high-dose chemotherapy with hematopoietic stem cell supportBetsy Paul, James A Trovato, Jennifer Thompson, et al.The Prostate|August 20, 2009
The relationship of neuroendocrine carcinomas to anti-tumor therapies in TRAMP miceYao Tang, Linbo Wang, Olga Goloubeva, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2008
Elevated expression of glutathione S-transferase pi and p53 confers poor prognosis in head and neck cancer patients treated with chemoradiotherapy but not radiotherapy aloneLisa Schumaker, Nikolaos Nikitakis, Olga Goloubeva, et al.Pageof 9